|
| Status |
Public on Apr 17, 2021 |
| Title |
Next Generation Sequencing of DIO Liver steatosis DMSO vs NCT (HNF4a agonist) |
| Organism |
Mus musculus |
| Experiment type |
Expression profiling by high throughput sequencing
|
| Summary |
Mice rendered obese with high fat diet were treated by IP injection with N-trans caffeoyltyramine (NCT) (200 mg/kg bid) for 14 days, followed by harvesting of the liver for analysis, including RNA isolation.
|
| |
|
| Overall design |
High fat diet induced non-alcoholic fatty liver (NAFLD) treated with DMSO or NCT compound.
|
| |
|
| Contributor(s) |
Levine F |
| Citation(s) |
34117215, 35087037 |
| |
| Submission date |
Apr 16, 2021 |
| Last update date |
Oct 11, 2023 |
| Contact name |
Brian Patrick James |
| E-mail(s) |
bjames@sanfordburnham.org
|
| Organization name |
Sanford Burnham Prebys Medical Discovery Institute
|
| Department |
Genomics
|
| Lab |
James
|
| Street address |
10901 North Torrey Pines Road
|
| City |
San Diego |
| State/province |
CA |
| ZIP/Postal code |
92037 |
| Country |
USA |
| |
|
| Platforms (1) |
| GPL19057 |
Illumina NextSeq 500 (Mus musculus) |
|
| Samples (6)
|
|
| Relations |
| BioProject |
PRJNA722504 |
| SRA |
SRP315129 |
Less...
More...